A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy

Recent reports underscore the unparalleled potential of antisense-oligonucleotide (ASO)-based approaches to ameliorate various pathological conditions. However, in vivo studies validating the effectiveness of a short ASO (<10-mer) in the context of a human disease have not been performed. One dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Keil, Jeffrey M, Seo, Joonbae, Howell, Matthew D, Hsu, Walter H, Singh, Ravindra N, DiDonato, Christine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121513/
https://www.ncbi.nlm.nih.gov/pubmed/25004100
http://dx.doi.org/10.1038/mtna.2014.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121513/
https://www.ncbi.nlm.nih.gov/pubmed/25004100
http://dx.doi.org/10.1038/mtna.2014.23

Ejemplares similares